HEADER CELL CYCLE 07-APR-07 2UYI TITLE CRYSTAL STRUCTURE OF KSP IN COMPLEX WITH ADP AND THIOPHENE TITLE 2 CONTAINING INHIBITOR 33 COMPND MOL_ID: 1; COMPND 2 MOLECULE: KINESIN-LIKE PROTEIN KIF11; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, RESIDUES 1-368; COMPND 5 SYNONYM: KINESIN-RELATED MOTOR PROTEIN EG5, KINESIN-LIKE COMPND 6 SPINDLE PROTEIN HKSP, THYROID RECEPTOR-INTERACTING COMPND 7 PROTEIN 5, TRIP-5, KINESIN-LIKE PROTEIN 1, KINESIN COMPND 8 SPINDLE PROTEIN; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PET30 KEYWDS KSP, EG5, COMPLEX, MITOSIS, THIOPHENE, INHIBITOR, KEYWDS 2 NUCLEOTIDE-BINDING, KINESIN SPINDLE PROTEIN, MOTOR KEYWDS 3 PROTEIN, CELL DIVISION, PHOSPHORYLATION, CELL CYCLE, KEYWDS 4 MICROTUBULE, COILED COIL, ATP-BINDING EXPDTA X-RAY DIFFRACTION AUTHOR T.T.LEE REVDAT 3 24-FEB-09 2UYI 1 VERSN REVDAT 2 26-JUN-07 2UYI 1 JRNL REVDAT 1 22-MAY-07 2UYI 0 JRNL AUTH A.B.PINKERTON,T.T.LEE,T.Z.HOFFMAN,Y.WANG, JRNL AUTH 2 M.KAHRAMAN,T.G.COOK,D.SEVERANCE,T.C.GAHMAN, JRNL AUTH 3 S.A.NOBLE,A.K.SHIAU,R.L.DAVIS JRNL TITL SYNTHESIS AND SAR OF THIOPHENE CONTAINING KINESIN JRNL TITL 2 SPINDLE PROTEIN (KSP) INHIBITORS. JRNL REF BIOORG.MED.CHEM.LETT. V. 17 3562 2007 JRNL REFN ISSN 0960-894X JRNL PMID 17498954 JRNL DOI 10.1016/J.BMCL.2007.04.076 REMARK 2 REMARK 2 RESOLUTION. 2.1 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 79.56 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 96.9 REMARK 3 NUMBER OF REFLECTIONS : 48485 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.240 REMARK 3 R VALUE (WORKING SET) : 0.237 REMARK 3 FREE R VALUE : 0.294 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2615 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.15 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3510 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2610 REMARK 3 BIN FREE R VALUE SET COUNT : 192 REMARK 3 BIN FREE R VALUE : 0.3770 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5198 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 106 REMARK 3 SOLVENT ATOMS : 276 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 32.58 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.51000 REMARK 3 B22 (A**2) : -1.02000 REMARK 3 B33 (A**2) : 0.50000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.236 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.215 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.151 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.541 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.929 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.899 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5386 ; 0.024 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7294 ; 2.268 ; 1.994 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 658 ; 7.405 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 234 ;35.462 ;24.017 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 976 ;19.900 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 42 ;17.611 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 850 ; 0.163 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3954 ; 0.009 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2465 ; 0.232 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 3541 ; 0.308 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 340 ; 0.164 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 63 ; 0.244 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 16 ; 0.197 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3440 ; 1.419 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5350 ; 2.204 ; 2.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2238 ; 3.360 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1944 ; 4.895 ; 4.500 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. REMARK 4 REMARK 4 2UYI COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-APR-07. REMARK 100 THE PDBE ID CODE IS EBI-32212. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-JUL-06 REMARK 200 TEMPERATURE (KELVIN) : 277.0 REMARK 200 PH : 6.00 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 52737 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 200 DATA REDUNDANCY : 6.100 REMARK 200 R MERGE (I) : 0.14000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: OTHER REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 54 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.7 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM BIS-TRIS (PH 6.0) 200 MM REMARK 280 AMMONIUM SULFATE, AND 18-20% PEG3350. 10 MM SRCL2 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 34.76750 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 79.51800 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 40.06950 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 79.51800 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 34.76750 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 40.06950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 GENERATING THE BIOMOLECULE REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 SER A 3 REMARK 465 GLN A 4 REMARK 465 PRO A 5 REMARK 465 ASN A 6 REMARK 465 SER A 7 REMARK 465 SER A 8 REMARK 465 ALA A 9 REMARK 465 LYS A 10 REMARK 465 LYS A 11 REMARK 465 LYS A 12 REMARK 465 GLU A 13 REMARK 465 GLU A 14 REMARK 465 LYS A 15 REMARK 465 ILE A 272 REMARK 465 GLY A 273 REMARK 465 ARG A 274 REMARK 465 SER A 275 REMARK 465 GLY A 276 REMARK 465 ALA A 277 REMARK 465 VAL A 278 REMARK 465 ASP A 279 REMARK 465 LYS A 280 REMARK 465 ARG A 281 REMARK 465 ALA A 282 REMARK 465 ARG A 283 REMARK 465 GLU A 284 REMARK 465 ALA A 285 REMARK 465 GLY A 286 REMARK 465 ASN A 287 REMARK 465 PRO A 363 REMARK 465 GLU A 364 REMARK 465 VAL A 365 REMARK 465 ASN A 366 REMARK 465 GLN A 367 REMARK 465 LYS A 368 REMARK 465 MET B 1 REMARK 465 ALA B 2 REMARK 465 SER B 3 REMARK 465 GLN B 4 REMARK 465 PRO B 5 REMARK 465 ASN B 6 REMARK 465 SER B 7 REMARK 465 SER B 8 REMARK 465 ALA B 9 REMARK 465 LYS B 10 REMARK 465 LYS B 11 REMARK 465 LYS B 12 REMARK 465 GLU B 13 REMARK 465 GLU B 14 REMARK 465 LYS B 15 REMARK 465 ILE B 272 REMARK 465 GLY B 273 REMARK 465 ARG B 274 REMARK 465 SER B 275 REMARK 465 GLY B 276 REMARK 465 ALA B 277 REMARK 465 VAL B 278 REMARK 465 ASP B 279 REMARK 465 LYS B 280 REMARK 465 ARG B 281 REMARK 465 ALA B 282 REMARK 465 ARG B 283 REMARK 465 GLU B 284 REMARK 465 ALA B 285 REMARK 465 GLY B 286 REMARK 465 ASN B 287 REMARK 465 PRO B 363 REMARK 465 GLU B 364 REMARK 465 VAL B 365 REMARK 465 ASN B 366 REMARK 465 GLN B 367 REMARK 465 LYS B 368 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 CYS A 87 CB CYS A 87 SG -0.147 REMARK 500 GLY B 268 C GLY B 268 O 0.098 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 CYS A 87 CA - CB - SG ANGL. DEV. = -6.8 DEGREES REMARK 500 MET A 115 CG - SD - CE ANGL. DEV. = -11.5 DEGREES REMARK 500 LEU A 168 CB - CG - CD1 ANGL. DEV. = -11.5 DEGREES REMARK 500 LEU A 341 CA - CB - CG ANGL. DEV. = 19.3 DEGREES REMARK 500 MET B 115 CG - SD - CE ANGL. DEV. = -10.9 DEGREES REMARK 500 ARG B 221 NE - CZ - NH2 ANGL. DEV. = -3.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 17 119.14 -176.77 REMARK 500 SER A 36 53.77 37.87 REMARK 500 ASN A 173 105.13 -55.63 REMARK 500 ALA A 230 41.17 37.48 REMARK 500 PRO A 310 37.65 -69.00 REMARK 500 LYS B 17 93.81 -177.55 REMARK 500 PRO B 121 153.56 -49.36 REMARK 500 ASP B 149 36.66 -158.70 REMARK 500 SER B 175 -93.92 -79.60 REMARK 500 ALA B 230 45.75 35.15 REMARK 500 ARG B 305 66.18 35.59 REMARK 500 PRO B 310 46.09 -73.67 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 ILE A 288 20.7 L L OUTSIDE RANGE REMARK 500 VAL B 85 24.9 L L OUTSIDE RANGE REMARK 500 THR B 148 24.9 L L OUTSIDE RANGE REMARK 500 LYS B 191 22.1 L L OUTSIDE RANGE REMARK 500 THR B 223 24.6 L L OUTSIDE RANGE REMARK 500 ASN B 271 20.0 L L OUTSIDE RANGE REMARK 500 ILE B 288 24.7 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 603 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH A2135 O REMARK 620 2 HOH A2136 O 95.4 REMARK 620 3 HOH A2037 O 84.6 173.9 REMARK 620 4 HOH A2081 O 87.8 89.3 84.5 REMARK 620 5 THR A 112 OG1 171.9 92.7 87.4 93.0 REMARK 620 6 ADP A 601 O1B 91.1 93.5 92.7 177.1 87.8 REMARK 620 N 1 2 3 4 5 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B 603 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 HOH B2084 O REMARK 620 2 HOH B2096 O 85.4 REMARK 620 3 HOH B2134 O 87.3 89.3 REMARK 620 4 THR B 112 OG1 87.4 84.1 171.9 REMARK 620 5 ADP B 601 O1B 175.3 90.0 92.4 92.4 REMARK 620 6 HOH B2136 O 95.5 177.9 92.7 94.0 89.2 REMARK 620 N 1 2 3 4 5 REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 603 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG B 603 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ADP A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE K02 A 604 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ADP B 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE K02 B 604 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1II6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE MITOTIC KINESIN EG5 REMARK 900 IN COMPLEXWITH MG-ADP. REMARK 900 RELATED ID: 1Q0B RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE MOTOR PROTEIN KSP REMARK 900 IN COMPLEX WITHADP AND MONASTROL REMARK 900 RELATED ID: 1X88 RELATED DB: PDB REMARK 900 HUMAN EG5 MOTOR DOMAIN BOUND TO MG-ADP REMARK 900 AND MONASTROL REMARK 900 RELATED ID: 1YRS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF KSP IN COMPLEX WITH REMARK 900 INHIBITOR 1 REMARK 900 RELATED ID: 2FKY RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF KSP IN COMPLEX WITH REMARK 900 INHIBITOR 13 REMARK 900 RELATED ID: 2FL2 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF KSP IN COMPLEX WITH REMARK 900 INHIBITOR 19 REMARK 900 RELATED ID: 2FL6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF KSP IN COMPLEX WITH REMARK 900 INHIBITOR 6 REMARK 900 RELATED ID: 2G1Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF KSP IN COMPLEX WITH REMARK 900 INHIBITOR 9H REMARK 900 RELATED ID: 2GM1 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE MITOTIC KINESIN EG5 REMARK 900 IN COMPLEXWITH MG-ADP AND N-(3- REMARK 900 AMINOPROPYL)-N-((3-BENZYL-5-CHLORO-4-OXO- REMARK 900 3,4-DIHYDROPYRROLO[2,1-F][1,2,4] REMARK 900 TRIAZIN-2-YL)(CYCLOPROPYL)METHYL)-4- REMARK 900 METHYLBENZAMIDE DBREF 2UYI A 1 368 UNP P52732 KIF11_HUMAN 1 368 DBREF 2UYI B 1 368 UNP P52732 KIF11_HUMAN 1 368 SEQRES 1 A 368 MET ALA SER GLN PRO ASN SER SER ALA LYS LYS LYS GLU SEQRES 2 A 368 GLU LYS GLY LYS ASN ILE GLN VAL VAL VAL ARG CYS ARG SEQRES 3 A 368 PRO PHE ASN LEU ALA GLU ARG LYS ALA SER ALA HIS SER SEQRES 4 A 368 ILE VAL GLU CYS ASP PRO VAL ARG LYS GLU VAL SER VAL SEQRES 5 A 368 ARG THR GLY GLY LEU ALA ASP LYS SER SER ARG LYS THR SEQRES 6 A 368 TYR THR PHE ASP MET VAL PHE GLY ALA SER THR LYS GLN SEQRES 7 A 368 ILE ASP VAL TYR ARG SER VAL VAL CYS PRO ILE LEU ASP SEQRES 8 A 368 GLU VAL ILE MET GLY TYR ASN CYS THR ILE PHE ALA TYR SEQRES 9 A 368 GLY GLN THR GLY THR GLY LYS THR PHE THR MET GLU GLY SEQRES 10 A 368 GLU ARG SER PRO ASN GLU GLU TYR THR TRP GLU GLU ASP SEQRES 11 A 368 PRO LEU ALA GLY ILE ILE PRO ARG THR LEU HIS GLN ILE SEQRES 12 A 368 PHE GLU LYS LEU THR ASP ASN GLY THR GLU PHE SER VAL SEQRES 13 A 368 LYS VAL SER LEU LEU GLU ILE TYR ASN GLU GLU LEU PHE SEQRES 14 A 368 ASP LEU LEU ASN PRO SER SER ASP VAL SER GLU ARG LEU SEQRES 15 A 368 GLN MET PHE ASP ASP PRO ARG ASN LYS ARG GLY VAL ILE SEQRES 16 A 368 ILE LYS GLY LEU GLU GLU ILE THR VAL HIS ASN LYS ASP SEQRES 17 A 368 GLU VAL TYR GLN ILE LEU GLU LYS GLY ALA ALA LYS ARG SEQRES 18 A 368 THR THR ALA ALA THR LEU MET ASN ALA TYR SER SER ARG SEQRES 19 A 368 SER HIS SER VAL PHE SER VAL THR ILE HIS MET LYS GLU SEQRES 20 A 368 THR THR ILE ASP GLY GLU GLU LEU VAL LYS ILE GLY LYS SEQRES 21 A 368 LEU ASN LEU VAL ASP LEU ALA GLY SER GLU ASN ILE GLY SEQRES 22 A 368 ARG SER GLY ALA VAL ASP LYS ARG ALA ARG GLU ALA GLY SEQRES 23 A 368 ASN ILE ASN GLN SER LEU LEU THR LEU GLY ARG VAL ILE SEQRES 24 A 368 THR ALA LEU VAL GLU ARG THR PRO HIS VAL PRO TYR ARG SEQRES 25 A 368 GLU SER LYS LEU THR ARG ILE LEU GLN ASP SER LEU GLY SEQRES 26 A 368 GLY ARG THR ARG THR SER ILE ILE ALA THR ILE SER PRO SEQRES 27 A 368 ALA SER LEU ASN LEU GLU GLU THR LEU SER THR LEU GLU SEQRES 28 A 368 TYR ALA HIS ARG ALA LYS ASN ILE LEU ASN LYS PRO GLU SEQRES 29 A 368 VAL ASN GLN LYS SEQRES 1 B 368 MET ALA SER GLN PRO ASN SER SER ALA LYS LYS LYS GLU SEQRES 2 B 368 GLU LYS GLY LYS ASN ILE GLN VAL VAL VAL ARG CYS ARG SEQRES 3 B 368 PRO PHE ASN LEU ALA GLU ARG LYS ALA SER ALA HIS SER SEQRES 4 B 368 ILE VAL GLU CYS ASP PRO VAL ARG LYS GLU VAL SER VAL SEQRES 5 B 368 ARG THR GLY GLY LEU ALA ASP LYS SER SER ARG LYS THR SEQRES 6 B 368 TYR THR PHE ASP MET VAL PHE GLY ALA SER THR LYS GLN SEQRES 7 B 368 ILE ASP VAL TYR ARG SER VAL VAL CYS PRO ILE LEU ASP SEQRES 8 B 368 GLU VAL ILE MET GLY TYR ASN CYS THR ILE PHE ALA TYR SEQRES 9 B 368 GLY GLN THR GLY THR GLY LYS THR PHE THR MET GLU GLY SEQRES 10 B 368 GLU ARG SER PRO ASN GLU GLU TYR THR TRP GLU GLU ASP SEQRES 11 B 368 PRO LEU ALA GLY ILE ILE PRO ARG THR LEU HIS GLN ILE SEQRES 12 B 368 PHE GLU LYS LEU THR ASP ASN GLY THR GLU PHE SER VAL SEQRES 13 B 368 LYS VAL SER LEU LEU GLU ILE TYR ASN GLU GLU LEU PHE SEQRES 14 B 368 ASP LEU LEU ASN PRO SER SER ASP VAL SER GLU ARG LEU SEQRES 15 B 368 GLN MET PHE ASP ASP PRO ARG ASN LYS ARG GLY VAL ILE SEQRES 16 B 368 ILE LYS GLY LEU GLU GLU ILE THR VAL HIS ASN LYS ASP SEQRES 17 B 368 GLU VAL TYR GLN ILE LEU GLU LYS GLY ALA ALA LYS ARG SEQRES 18 B 368 THR THR ALA ALA THR LEU MET ASN ALA TYR SER SER ARG SEQRES 19 B 368 SER HIS SER VAL PHE SER VAL THR ILE HIS MET LYS GLU SEQRES 20 B 368 THR THR ILE ASP GLY GLU GLU LEU VAL LYS ILE GLY LYS SEQRES 21 B 368 LEU ASN LEU VAL ASP LEU ALA GLY SER GLU ASN ILE GLY SEQRES 22 B 368 ARG SER GLY ALA VAL ASP LYS ARG ALA ARG GLU ALA GLY SEQRES 23 B 368 ASN ILE ASN GLN SER LEU LEU THR LEU GLY ARG VAL ILE SEQRES 24 B 368 THR ALA LEU VAL GLU ARG THR PRO HIS VAL PRO TYR ARG SEQRES 25 B 368 GLU SER LYS LEU THR ARG ILE LEU GLN ASP SER LEU GLY SEQRES 26 B 368 GLY ARG THR ARG THR SER ILE ILE ALA THR ILE SER PRO SEQRES 27 B 368 ALA SER LEU ASN LEU GLU GLU THR LEU SER THR LEU GLU SEQRES 28 B 368 TYR ALA HIS ARG ALA LYS ASN ILE LEU ASN LYS PRO GLU SEQRES 29 B 368 VAL ASN GLN LYS HET MG A 603 1 HET MG B 603 1 HET ADP A 601 27 HET K02 A 604 25 HET ADP B 601 27 HET K02 B 604 25 HETNAM MG MAGNESIUM ION HETNAM ADP ADENOSINE-5'-DIPHOSPHATE HETNAM K02 (5R)-N,N-DIETHYL-5-METHYL-2-[(THIOPHEN-2- HETNAM 2 K02 YLCARBONYL)AMINO]-4,5,6,7-TETRAHYDRO-1- HETNAM 3 K02 BENZOTHIOPHENE-3-CARBOXAMIDE FORMUL 3 MG 2(MG 2+) FORMUL 5 ADP 2(C10 H15 N5 O10 P2) FORMUL 6 K02 2(C19 H24 N2 O2 S2) FORMUL 9 HOH *276(H2 O1) HELIX 1 1 ASN A 29 ALA A 35 1 7 HELIX 2 2 LYS A 77 VAL A 85 1 9 HELIX 3 3 VAL A 85 MET A 95 1 11 HELIX 4 4 GLY A 110 GLU A 116 1 7 HELIX 5 5 SER A 120 GLU A 124 5 5 HELIX 6 6 GLY A 134 ASN A 150 1 17 HELIX 7 7 ASN A 206 ASP A 208 5 3 HELIX 8 8 GLU A 209 MET A 228 1 20 HELIX 9 9 ALA A 230 SER A 235 1 6 HELIX 10 10 ASN A 289 ARG A 305 1 17 HELIX 11 11 PRO A 310 GLU A 313 5 4 HELIX 12 12 SER A 314 GLN A 321 1 8 HELIX 13 13 ASP A 322 LEU A 324 5 3 HELIX 14 14 ALA A 339 LEU A 341 5 3 HELIX 15 15 ASN A 342 LYS A 357 1 16 HELIX 16 16 ASN B 29 LYS B 34 1 6 HELIX 17 17 LYS B 77 VAL B 85 1 9 HELIX 18 18 VAL B 85 MET B 95 1 11 HELIX 19 19 GLY B 110 GLU B 116 1 7 HELIX 20 20 THR B 126 ASP B 130 5 5 HELIX 21 21 GLY B 134 LEU B 147 1 14 HELIX 22 22 ASN B 206 ASP B 208 5 3 HELIX 23 23 GLU B 209 MET B 228 1 20 HELIX 24 24 ALA B 230 SER B 235 1 6 HELIX 25 25 ASN B 289 GLU B 304 1 16 HELIX 26 26 PRO B 310 GLU B 313 5 4 HELIX 27 27 SER B 314 LEU B 320 1 7 HELIX 28 28 GLN B 321 LEU B 324 5 4 HELIX 29 29 ALA B 339 LEU B 341 5 3 HELIX 30 30 ASN B 342 LYS B 357 1 16 SHEET 1 AA 2 LYS A 17 ASN A 18 0 SHEET 2 AA 2 LEU A 360 ASN A 361 -1 O ASN A 361 N LYS A 17 SHEET 1 AB 8 MET A 70 PHE A 72 0 SHEET 2 AB 8 GLN A 20 CYS A 25 1 O VAL A 23 N PHE A 72 SHEET 3 AB 8 ARG A 329 ILE A 336 1 O THR A 330 N GLN A 20 SHEET 4 AB 8 ASN A 98 GLY A 105 1 O ASN A 98 N ARG A 329 SHEET 5 AB 8 GLU A 254 ASP A 265 1 O LYS A 260 N CYS A 99 SHEET 6 AB 8 HIS A 236 THR A 248 -1 O SER A 237 N ASP A 265 SHEET 7 AB 8 THR A 152 TYR A 164 -1 O GLU A 153 N LYS A 246 SHEET 8 AB 8 ILE A 202 VAL A 204 -1 O ILE A 202 N VAL A 158 SHEET 1 AC 8 MET A 70 PHE A 72 0 SHEET 2 AC 8 GLN A 20 CYS A 25 1 O VAL A 23 N PHE A 72 SHEET 3 AC 8 ARG A 329 ILE A 336 1 O THR A 330 N GLN A 20 SHEET 4 AC 8 ASN A 98 GLY A 105 1 O ASN A 98 N ARG A 329 SHEET 5 AC 8 GLU A 254 ASP A 265 1 O LYS A 260 N CYS A 99 SHEET 6 AC 8 HIS A 236 THR A 248 -1 O SER A 237 N ASP A 265 SHEET 7 AC 8 THR A 152 TYR A 164 -1 O GLU A 153 N LYS A 246 SHEET 8 AC 8 GLU A 167 ASP A 170 -1 O GLU A 167 N TYR A 164 SHEET 1 AD 3 VAL A 41 ASP A 44 0 SHEET 2 AD 3 GLU A 49 ARG A 53 -1 O GLU A 49 N ASP A 44 SHEET 3 AD 3 ARG A 63 THR A 67 -1 O LYS A 64 N VAL A 52 SHEET 1 AE 2 GLN A 183 ASP A 186 0 SHEET 2 AE 2 VAL A 194 LYS A 197 -1 O ILE A 195 N PHE A 185 SHEET 1 BA 8 MET B 70 PHE B 72 0 SHEET 2 BA 8 GLN B 20 CYS B 25 1 O VAL B 23 N PHE B 72 SHEET 3 BA 8 ARG B 329 ILE B 336 1 O THR B 330 N GLN B 20 SHEET 4 BA 8 ASN B 98 GLY B 105 1 O ASN B 98 N ARG B 329 SHEET 5 BA 8 GLU B 254 ASP B 265 1 O LYS B 260 N CYS B 99 SHEET 6 BA 8 HIS B 236 THR B 248 -1 O SER B 237 N ASP B 265 SHEET 7 BA 8 THR B 152 TYR B 164 -1 O GLU B 153 N LYS B 246 SHEET 8 BA 8 ILE B 202 VAL B 204 -1 O ILE B 202 N VAL B 158 SHEET 1 BB 8 MET B 70 PHE B 72 0 SHEET 2 BB 8 GLN B 20 CYS B 25 1 O VAL B 23 N PHE B 72 SHEET 3 BB 8 ARG B 329 ILE B 336 1 O THR B 330 N GLN B 20 SHEET 4 BB 8 ASN B 98 GLY B 105 1 O ASN B 98 N ARG B 329 SHEET 5 BB 8 GLU B 254 ASP B 265 1 O LYS B 260 N CYS B 99 SHEET 6 BB 8 HIS B 236 THR B 248 -1 O SER B 237 N ASP B 265 SHEET 7 BB 8 THR B 152 TYR B 164 -1 O GLU B 153 N LYS B 246 SHEET 8 BB 8 GLU B 167 ASP B 170 -1 O GLU B 167 N TYR B 164 SHEET 1 BC 3 VAL B 41 ASP B 44 0 SHEET 2 BC 3 GLU B 49 ARG B 53 -1 O GLU B 49 N ASP B 44 SHEET 3 BC 3 ARG B 63 THR B 67 -1 O LYS B 64 N VAL B 52 SHEET 1 BD 2 GLN B 183 ASP B 186 0 SHEET 2 BD 2 VAL B 194 LYS B 197 -1 O ILE B 195 N PHE B 185 LINK MG MG A 603 O HOH A2135 1555 1555 2.24 LINK MG MG A 603 O HOH A2136 1555 1555 2.04 LINK MG MG A 603 O HOH A2037 1555 1555 2.06 LINK MG MG A 603 O HOH A2081 1555 1555 2.11 LINK MG MG A 603 OG1 THR A 112 1555 1555 1.88 LINK MG MG A 603 O1B ADP A 601 1555 1555 2.11 LINK MG MG B 603 O HOH B2096 1555 1555 2.17 LINK MG MG B 603 O HOH B2134 1555 1555 2.42 LINK MG MG B 603 OG1 THR B 112 1555 1555 2.02 LINK MG MG B 603 O1B ADP B 601 1555 1555 2.07 LINK MG MG B 603 O HOH B2136 1555 1555 2.15 LINK MG MG B 603 O HOH B2084 1555 1555 2.24 SITE 1 AC1 6 THR A 112 ADP A 601 HOH A2037 HOH A2081 SITE 2 AC1 6 HOH A2135 HOH A2136 SITE 1 AC2 6 THR B 112 ADP B 601 HOH B2084 HOH B2096 SITE 2 AC2 6 HOH B2134 HOH B2136 SITE 1 AC3 20 ARG A 24 ARG A 26 PRO A 27 GLN A 106 SITE 2 AC3 20 THR A 107 GLY A 108 THR A 109 GLY A 110 SITE 3 AC3 20 LYS A 111 THR A 112 PHE A 113 GLU A 118 SITE 4 AC3 20 MG A 603 HOH A2008 HOH A2037 HOH A2134 SITE 5 AC3 20 HOH A2135 HOH A2136 HOH A2137 HOH A2138 SITE 1 AC4 13 GLU A 116 GLU A 118 ARG A 119 TRP A 127 SITE 2 AC4 13 ASP A 130 ALA A 133 PRO A 137 LEU A 214 SITE 3 AC4 13 GLU A 215 GLY A 217 ALA A 218 ARG A 221 SITE 4 AC4 13 HOH A2039 SITE 1 AC5 18 ARG B 24 ARG B 26 PRO B 27 GLN B 106 SITE 2 AC5 18 GLY B 108 THR B 109 GLY B 110 LYS B 111 SITE 3 AC5 18 THR B 112 PHE B 113 GLU B 118 MG B 603 SITE 4 AC5 18 HOH B2096 HOH B2133 HOH B2134 HOH B2136 SITE 5 AC5 18 HOH B2137 HOH B2138 SITE 1 AC6 12 GLU B 116 GLU B 118 ARG B 119 TRP B 127 SITE 2 AC6 12 ALA B 133 PRO B 137 TYR B 211 LEU B 214 SITE 3 AC6 12 GLU B 215 GLY B 217 ALA B 218 ARG B 221 CRYST1 69.535 80.139 159.036 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014381 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012478 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006288 0.00000